Open Beta
TREN
MetriLume
TREN

US marketsBIOE

SEC-sourced researchBeta

BIOE

Bio Essence Corp

Company comparison ↗

Data passport

CIK
0001723059
Exchange
OTC
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Mar 27, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 323,940.0000 USD; December 2025: 1,897,566.0000 USD1.9M USD0 USD0December 2024December 2025
BIOE · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024323,940.0000Mar 27, 2026
December 20251,897,566.0000Mar 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,897,566.0000896,197.00001,569,753.0000422,474.00002,495,367.0000Mar 27, 2026
December 2024323,940.0000-1,308,796.0000623,865.0000281,024.00003,250,114.0000Mar 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.9MDecember 2025Mar 27, 202610-K
Previous period revenueRevenues$323.94KDecember 2024Mar 27, 202610-K
Net incomeNetIncomeLoss$896.2KDecember 2025Mar 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$1.57MDecember 2025Mar 27, 202610-K
Total assetsAssets$422.47KDecember 2025Mar 27, 202610-K
Total liabilitiesLiabilities$2.5MDecember 2025Mar 27, 202610-K

New filings

Explore methodology ↗